Rosnilimab

Drug identity checked against registry records

Also recorded as ANB030

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)NCT06041269ANABPhase 2Active not recruiting2024-11-29Estimated
A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)NCT06127043ANABPhase 2Active not recruiting2026-01Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.